Scientists developed a new drug that successfully targets the previously undruggable KRAS mutation which drives most pancreatic cancers nearly doubling patient survival in trials.
Tag: clinical trials
GLP-1 Drugs at Lower Doses Shown to Maintain Weight Loss Outcomes in New Trials
Two clinical trials found that reduced doses of GLP-1 weight-loss medications and newer oral pills like Foundayo can maintain weight loss outcomes lowering costs and side effects.
Lower-Dose GLP-1 Drugs or Oral Pill Foundayo Can Maintain Weight Loss Per Clinical Trials
Two clinical trials suggest patients can switch to lighter formulations without regaining the weight they lost.